Yang 2020d.
| Study characteristics | |||
| Patient Sampling |
Purpose: to identify differences in CT imaging and clinical features between COVID‐19 and
influenza pneumonia in the early stage, and to identify the most valuable features in the differential
diagnosis Design: diagnostic case‐control study, retrospective multicentre with historic control group Recruitment: cases: confirmed SARS‐CoV‐2 patients; controls: influenza pneumonia patients (1 January 2015‐30 September 2019 from 2 hospitals) Sample size: n = 121 (cases = 73) Inclusion criteria: patients confirmed with SARS‐CoV‐2; controls: patients who had 9 respiratory pathogen IgM antibody tested from January 2015‐September 2019 Exclusion criteria: cases: not specified controls:
No CT date, no clinical date |
||
| Patient characteristics and setting |
Facility cases: positive RT‐PCR for 2019‐nCov Facility controls: influenza pneumonia Country: China Dates: 1 January 2020‐15 February 2020 Symptoms and severity: all patients in early stages of COVID‐19 or influenza pneumonia Demographics: M/F: cases 41/32, controls 30/18 mean age: cases 41.9, controls 40.4 Exposure history: not specified |
||
| Index tests |
|
||
| Target condition and reference standard(s) |
|
||
| Flow and timing | Time interval unclear | ||
| Comparative | |||
| Notes | Overlaps with Chen X 2020 | ||
| Methodological quality | |||
| Item | Authors' judgement | Risk of bias | Applicability concerns |
| DOMAIN 1: Patient Selection | |||
| Was a consecutive or random sample of patients enrolled? | Yes | ||
| Was a case‐control design avoided? | No | ||
| Did the study avoid inappropriate exclusions? | Unclear | ||
| Did the study avoid inappropriate inclusions? | No | ||
| Could the selection of patients have introduced bias? | High risk | ||
| Are there concerns that the included patients and setting do not match the review question? | High | ||
| DOMAIN 2: Index Test (All tests) | |||
| Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
| If a threshold was used, was it pre‐specified? | No | ||
| Could the conduct or interpretation of the index test have introduced bias? | High risk | ||
| Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
| DOMAIN 3: Reference Standard | |||
| Is the reference standards likely to correctly classify the target condition? | Yes | ||
| Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
| Could the reference standard, its conduct, or its interpretation have introduced bias? | High risk | ||
| Are there concerns that the target condition as defined by the reference standard does not match the question? | High | ||
| DOMAIN 4: Flow and Timing | |||
| Was there an appropriate interval between index test and reference standard? | Unclear | ||
| Did all patients receive the same reference standard? | Yes | ||
| Were all patients included in the analysis? | Yes | ||
| Could the patient flow have introduced bias? | Unclear risk | ||